Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
11:44:53 EDT Thu 16 May 2024
Enter Symbol
or Name
USA
CA



T:FRX - FENNEC PHARMACEUTICALS INC. J - http://fennecpharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
FRX - T  0.59.27·9.400.29.47-0.05-0.51.614329.63  9.64  9.3215.43  9.0010:57:56May 1415 min RT 2¢
TSX - T0.59.27·9.400.29.32-0.20-2.10.2259.32  9.32  9.3215.43  9.0010:29:0815 min
Chi-X - X 9.47-0.05-0.50.1119.47  9.47  9.4710:57:5615 min
CX2 - H 9.64+0.121.30.1119.64  9.64  9.6410:02:1815 min
CXD - D 9.63+0.111.20.2179.63  9.63  9.6310:02:1815 min
TriAct - M 9.521.0918    Sep 11-2015 min

Recent Trades - Last 10 of 32
Time ETExPriceChangeVolumeBuyerSellerMarkers
11:18:32D9.32-0.201080 National Bank2 RBCE
11:18:32D9.32-0.201080 National Bank14 Virtu ITGE
11:18:27D9.35-0.171080 National Bank2 RBCE
11:05:33M9.52 7080 National Bank14 Virtu ITGE
11:05:26M9.46-0.0610079 CIBC7 TD Sec
10:57:56X9.47-0.0510079 CIBC79 CIBCK
10:57:26M9.47-0.05207 TD Sec79 CIBCE
10:36:31M9.39-0.1317 TD Sec14 Virtu ITGE
10:29:08T9.32-0.201009 BMO Nesbitt80 National BankKL
10:21:19M9.50-0.021080 National Bank14 Virtu ITGE

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-05-14 19:25C:FRX10.02SEDAR Interim MD & ASEDAR Interim MD & A
2024-05-14 19:19C:FRX10.02SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-05-14 10:38C:FRX13.72News ReleaseFennec Pharmaceuticals earns $12.83-million in Q1
2024-05-07 18:44C:FRX12.65News ReleaseFennec Pharmaceuticals to release Q1 results May 14
2024-04-01 15:47C:FRX15.10SEDAR Annual Information FormSEDAR Annual Information Form
2024-04-01 15:05C:FRX15.10SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-04-01 13:28C:FRX15.10SEDAR MD & ASEDAR MD & A
2024-03-21 09:50C:FRX13.18News ReleaseFennec loses $16.04-million (U.S.) in 2023
2024-03-19 09:27C:FRX13.18News ReleaseFennec to release fiscal 2023 results March 21
2024-03-18 02:32C:FRX13.18News ReleaseFennec enters Pedmarqsi licensing deal with Norgine
2024-02-29 12:24C:FRX12.89News ReleaseFennec expects revenue of $20.7M to $21.2M for 2023
2024-02-01 09:29C:FRXNews ReleaseFennec notes FDA reminder re Pedmark non-substitution
2023-12-05 09:27C:FRX12.55News ReleaseFennec closes $5-million investment from Petrichor
2023-11-10 17:44C:FRX10.75SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-10 17:43C:FRX10.75SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-06 11:15C:FRX10.96News ReleaseFennec loses $1.86-million (U.S.) in Q3 2023
2023-10-30 12:26C:FRX9.64News ReleaseFennec Pharmaceuticals to release Q3 results Nov. 6
2023-08-08 14:47C:FRX10.63SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-03 09:59C:FRX10.63News ReleaseFennec Pharmaceuticals loses $5.44-million (U.S.) in Q2
2023-07-31 12:59C:FRX11.27News ReleaseFennec Pharmaceuticals to release Q2 results Aug. 3